CVS Health Quarterly Cash Flow Statement
NYSE: CVSConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CVS Health free cash flow
In the quarter ended Jun 30, 2026, CVS Health generated $6.34 billion of operating cash flow and spent $691.0 million on capital expenditures. That left free cash flow of $5.65 billion, a free-cash-flow margin of 5.3% of revenue. Free cash flow was up 338.3% from the prior year's $1.29 billion.
CVS Health returned $878.0 million to shareholders through dividends, equal to 16% of free cash flow. Free cash flow covered dividend payments 6.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
CVS Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3.00B | 2.96B | 2.92B | -3.99B | 1.01B | 1.78B | 1.62B | 71.00M | 1.77B | 1.12B | 2.05B | 2.27B |
| Net Income growth (YoY) | +195.66% | +65.94% | +80.10% | -5719.72% | -42.70% | +58.54% | -20.71% | -96.87% | -7.63% | -47.53% | -12.22% | — |
| Depreciation & Amortization | 1.13B | 1.11B | 1.15B | 1.13B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B | 1.14B | 1.13B | 1.13B |
| Stock-Based Compensation | 176.00M | 266.00M | 135.00M | 138.00M | 136.00M | 126.00M | 137.00M | 133.00M | 133.00M | 137.00M | 127.00M | 154.00M |
| Change in Working Capital | 1.54B | -8.00M | -303.00M | -2.34B | 89.00M | 1.06B | -273.00M | -3.68B | 833.00M | 468.00M | -1.76B | -1.08B |
| Operating Cash Flow | 6.34B | 4.25B | 3.39B | 796.00M | 1.90B | 4.56B | 1.86B | -745.00M | 3.09B | 4.90B | -2.64B | 2.72B |
| Capital Expenditures | -691.00M | -849.00M | -784.00M | -698.00M | -607.00M | -743.00M | -768.00M | -670.00M | -638.00M | -705.00M | -911.00M | -545.00M |
| Investing Cash Flow | -1.88B | -874.00M | -2.00B | -2.09B | -1.02B | -762.00M | -547.00M | -3.35B | -1.63B | -2.09B | -1.24B | -771.00M |
| Dividends Paid | -878.00M | -847.00M | -845.00M | -846.00M | -866.00M | -840.00M | -838.00M | -837.00M | -858.00M | -840.00M | -779.00M | -779.00M |
| Share Repurchases | — | — | 0 | 0 | 0 | 0 | 0 | 1.00M | 3.00M | -3.03B | 1.00M | 3.00M |
| Debt Issued | — | — | 0 | 3.97B | — | — | 2.95B | 0 | 4.96B | 0 | 0 | 0 |
| Debt Repaid | -1.77B | -1.52B | -20.00M | -2.85B | -19.00M | -743.00M | -3.07B | -1.67B | -19.00M | -18.00M | -432.00M | -947.00M |
| Financing Cash Flow | -2.69B | -2.32B | -2.03B | -1.38B | 806.00M | -2.33B | 431.00M | -1.59B | 1.25B | -1.23B | -972.00M | -2.70B |
| Net Change in Cash | 1.77B | 1.06B | -640.00M | -2.67B | 1.68B | 1.46B | 1.74B | -5.68B | 2.71B | 1.58B | -4.85B | -752.00M |
| Free Cash Flow | 5.65B | 3.40B | 2.61B | 98.00M | 1.29B | 3.81B | 1.09B | -1.42B | 2.45B | 4.20B | -3.55B | 2.17B |
This table shows 12 quarterly periods of CVS Health's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CVS's reporting calendar. What is a cash flow statement?